UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo
|
2019-11-15 17:26
라인
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented positive data from its phase 2 and 3 SELECT-AXIS 1 tri...
by Lee Han-soo
|
2019-11-15 11:40
라인
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea said that it received the National Assembly's Hea...
by Lee Han-soo
|
2019-11-14 18:05
라인
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im
|
2019-11-14 15:27
라인
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently drawn the attention of local industry watchers concer...
by Lee Han-soo
|
2019-11-14 13:24
라인
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it plans to apply for a phase 1 trial to change antican...
by Lee Han-soo
|
2019-11-13 17:35
라인
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said that it has formally launched Euvipharm Joint Stock ...
by Lee Han-soo
|
2019-11-13 16:52
라인
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidine’s recall were sharply different from those of va...
by Kim Yun-mi
|
2019-11-13 15:51
라인
Daewoong releases trial results for autoimmune disease treatment in US
Daewoong Pharmaceutical has presented clinical trial results on DWP212525, ...
by Lee Han-soo
|
2019-11-12 14:09
라인
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
Spectrum, Hanmi’s U.S. partner, said Hanmi can secure 11.6 billion won ($9....
by Lee Han-soo
|
2019-11-11 18:02
라인
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunotherapy candidate being developed jointly by Genexine an...
by Jeong Sae-im
|
2019-11-11 13:36
라인
Medpacto releases trial results at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo
|
2019-11-11 13:27
라인
Yuhan, Cyclica to co-develop new drugs
Yuhan Corp. said that it would develop a new drug with Cyclica, a Canadian ...
by Lee Han-soo
|
2019-11-07 18:01
라인
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
Takeda Pharmaceutical Korea’s conflict between labor and management is risi...
by Kim Yun-mi
|
2019-11-07 16:10
라인
‘One-third of heart attack survivors overlook risk of recurrence’
Amgen Korea has released findings from a survey on Korean heart attack surv...
by Lee Han-soo
|
2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
AbbVie said it has obtained regulatory approval for an eight-week treatment...
by Kim Yun-mi
|
2019-11-06 16:00
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
Crystal Genomics and Daehwa Pharmaceutical said they have registered a pate...
by Lee Han-soo
|
2019-11-06 15:57
라인
Dong-A ST's treatment of nail athlete's foot dominates local market
Dong-A ST is strengthening its position in the toenail athlete's foot t...
by Lee Han-soo
|
2019-11-06 14:09
라인
Regulator to consider re-classifying choline alfoscerate as functional food
The Ministry of Food and Drug Safety has requested drugmakers to submit eff...
by Kim Yun-mi
|
2019-11-06 13:54
라인
Daewoong to sell Merck's cardiovascular disease treatment
Merck Biopharma Korea said that Daewoong would market Concor, its cardiovas...
by Lee Han-soo
|
2019-11-05 15:05
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top